...
search icon
iva-img

Inventiva Sa, Common Stock

IVA

NMQ

$2.2

-$0.02

(-0.9%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$118.34M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.00
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.81
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.53 L
$4.5 H
$2.2

About Inventiva Sa, Common Stock

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIVASectorS&P500
1-Week Return2.48%2.82%0.25%
1-Month Return-2.04%6.76%2.75%
3-Month Return-17.94%-1.54%4.11%
6-Month Return0.52%-2.35%11.01%
1-Year Return-42.31%4.47%23.11%
3-Year Return-81.47%12.29%36.82%
5-Year Return-83.43%43.39%85.01%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue7.00M372.00K4.19M12.18M17.48M[{"date":"2019-12-31","value":40.04,"profit":true},{"date":"2020-12-31","value":2.13,"profit":true},{"date":"2021-12-31","value":24,"profit":true},{"date":"2022-12-31","value":69.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue-846.00K1.02M995.00K(23.00K)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":83.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.84,"profit":true},{"date":"2023-12-31","value":-2.26,"profit":false}]
Gross Profit7.00M372.00K3.18M12.18M17.50M[{"date":"2019-12-31","value":39.99,"profit":true},{"date":"2020-12-31","value":2.13,"profit":true},{"date":"2021-12-31","value":18.15,"profit":true},{"date":"2022-12-31","value":69.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin100.00%100.00%75.75%100.00%100.13%[{"date":"2019-12-31","value":99.87,"profit":true},{"date":"2020-12-31","value":99.87,"profit":true},{"date":"2021-12-31","value":75.65,"profit":true},{"date":"2022-12-31","value":99.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses36.21M30.09M56.31M69.29M120.19M[{"date":"2019-12-31","value":30.13,"profit":true},{"date":"2020-12-31","value":25.04,"profit":true},{"date":"2021-12-31","value":46.85,"profit":true},{"date":"2022-12-31","value":57.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(30.31M)(29.72M)(52.11M)(57.11M)(102.71M)[{"date":"2019-12-31","value":-3031200000,"profit":false},{"date":"2020-12-31","value":-2971800000,"profit":false},{"date":"2021-12-31","value":-5211400000,"profit":false},{"date":"2022-12-31","value":-5711000000,"profit":false},{"date":"2023-12-31","value":-10270900000,"profit":false}]
Total Non-Operating Income/Expense233.00K(7.80M)2.76M5.63M(11.34M)[{"date":"2019-12-31","value":4.14,"profit":true},{"date":"2020-12-31","value":-138.57,"profit":false},{"date":"2021-12-31","value":48.95,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-201.4,"profit":false}]
Pre-Tax Income(30.22M)(33.62M)(49.27M)(54.29M)(109.82M)[{"date":"2019-12-31","value":-3021700000,"profit":false},{"date":"2020-12-31","value":-3362000000,"profit":false},{"date":"2021-12-31","value":-4927200000,"profit":false},{"date":"2022-12-31","value":-5429400000,"profit":false},{"date":"2023-12-31","value":-10981900000,"profit":false}]
Income Taxes4.00K(2.00M)364.00K(20.00K)607.00K[{"date":"2019-12-31","value":0.66,"profit":true},{"date":"2020-12-31","value":-329,"profit":false},{"date":"2021-12-31","value":59.97,"profit":true},{"date":"2022-12-31","value":-3.29,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(30.22M)(31.62M)(49.64M)(54.27M)(110.43M)[{"date":"2019-12-31","value":-3022100000,"profit":false},{"date":"2020-12-31","value":-3162300000,"profit":false},{"date":"2021-12-31","value":-4963600000,"profit":false},{"date":"2022-12-31","value":-5427400000,"profit":false},{"date":"2023-12-31","value":-11042600000,"profit":false}]
Income From Continuous Operations(30.22M)(33.62M)(49.64M)(54.27M)(110.42M)[{"date":"2019-12-31","value":-3021700000,"profit":false},{"date":"2020-12-31","value":-3362000000,"profit":false},{"date":"2021-12-31","value":-4963900000,"profit":false},{"date":"2022-12-31","value":-5427400000,"profit":false},{"date":"2023-12-31","value":-11042500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(30.22M)(31.62M)(49.64M)(54.27M)(110.43M)[{"date":"2019-12-31","value":-3022100000,"profit":false},{"date":"2020-12-31","value":-3162300000,"profit":false},{"date":"2021-12-31","value":-4963600000,"profit":false},{"date":"2022-12-31","value":-5427400000,"profit":false},{"date":"2023-12-31","value":-11042600000,"profit":false}]
EPS (Diluted)-(1.50)(1.71)(0.28)(2.66)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-149.55,"profit":false},{"date":"2021-12-31","value":-170.84,"profit":false},{"date":"2022-12-31","value":-27.58,"profit":false},{"date":"2023-12-31","value":-266,"profit":false}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IVA
ROA (LTM) -113.34%
ROE (LTM) -1642.76%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IVA
Trailing PE NM
Forward PE NM
P/S (TTM) 11.39
P/B 2.10
EV/R 10.08
EV/Ebitda NM

FAQs

What is Inventiva Sa share price today?

Inventiva Sa (IVA) share price today is $2.2

Can Indians buy Inventiva Sa shares?

Yes, Indians can buy shares of Inventiva Sa (IVA) on Vested. To buy Inventiva Sa from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IVA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Inventiva Sa be purchased?

Yes, you can purchase fractional shares of Inventiva Sa (IVA) via the Vested app. You can start investing in Inventiva Sa (IVA) with a minimum investment of $1.

How to invest in Inventiva Sa shares from India?

You can invest in shares of Inventiva Sa (IVA) via Vested in three simple steps:

  • Click on Sign Up or Invest in IVA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Inventiva Sa shares
What is Inventiva Sa 52-week high and low stock price?

The 52-week high price of Inventiva Sa (IVA) is $4.5. The 52-week low price of Inventiva Sa (IVA) is $1.53.

What is Inventiva Sa price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Inventiva Sa (IVA) is 2.10

What is the Market Cap of Inventiva Sa?

The market capitalization of Inventiva Sa (IVA) is $118.34M

What is Inventiva Sa’s stock symbol?

The stock symbol (or ticker) of Inventiva Sa is IVA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top